Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 37 (7), 388-98

Progranulin in Neurodegenerative Disease

Affiliations
Review

Progranulin in Neurodegenerative Disease

Terri L Petkau et al. Trends Neurosci.

Abstract

Loss-of-function mutations in the progranulin gene are a common cause of familial frontotemporal dementia (FTD). The purpose of this review is to summarize the role of progranulin in health and disease, because the field is now poised to begin examining therapeutics that alter endogenous progranulin levels. We first review the clinical and neuropathological phenotype of FTD patients carrying mutations in the progranulin gene, which suggests that progranulin-mediated neurodegeneration is multifactorial and influenced by other genetic and/or environmental factors. We then examine evidence for the role of progranulin in the brain with a focus on mouse model systems. A better understanding of the complexity of progranulin biology in the brain will help guide the development of progranulin-modulating therapies for neurodegenerative disease.

Similar articles

See all similar articles

Cited by 56 PubMed Central articles

See all "Cited by" articles

Publication types

Substances

LinkOut - more resources

Feedback